SCHEMBL31489707

SCHEMBL31489707

Cc1nn([C@H](c2ccc(F)cc2)C(C)(F)F)cc1-c1cc(C#N)cc(-c2ccn3nc(N)nc3c2)n1

nearest known ligand 0.34

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PIK3CG P48736 9/20 0.34
PIK3CD O00329 7/20 0.34
RIPK1 Q13546 1/20 0.33
PAK4 O96013 1/20 0.33
JAK1 P23458 1/20 0.33
PIK3CA P42336 1/20 0.33
PIK3CB P42338 1/20 0.33
CSNK1A1 P48729 1/20 0.33
AAK1 Q2M2I8 1/20 0.33
PIP4K2C Q8TBX8 1/20 0.33
CSNK1G1 Q9HCP0 1/20 0.33
ADORA2A P29274 2/20 0.30
KDM4E B2RXH2 1/20 0.30
ALDH1A1 P00352 1/20 0.30
GLA P06280 1/20 0.30
GAA P10253 1/20 0.30
PKM P14618 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31489319 0.88 RIPK1 (0.38) PIK3CGPIK3CDRIPK1PAK4JAK1
SCHEMBL31489631 0.88 RIPK1 (0.38) PIK3CGPIK3CDRIPK1PAK4JAK1
SCHEMBL31489329 0.87 PIK3CG (0.37) PIK3CGPIK3CDRIPK1PAK4JAK1
SCHEMBL31489187 0.87 PIK3CG (0.42) PIK3CGPIK3CDRIPK1PAK4JAK1
SCHEMBL31489688 0.87 PIK3CG (0.42) PIK3CGPIK3CDRIPK1PAK4JAK1
SCHEMBL31489299 0.83 RIPK1 (0.36) PIK3CGPIK3CDRIPK1PAK4JAK1
SCHEMBL31489640 0.83 PIK3CG (0.36) PIK3CGPIK3CDRIPK1PAK4JAK1
SCHEMBL31489738 0.83 PIK3CG (0.36) PIK3CGPIK3CDRIPK1PAK4JAK1
SCHEMBL31489339 0.83 PIK3CG (0.36) PIK3CGPIK3CDRIPK1PAK4JAK1
SCHEMBL31489894 0.82 RIPK1 (0.38) PIK3CGPIK3CDRIPK1PAK4JAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025072395-A1 TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2025-04-03 WO disclosed